A comparative randomized clinical trial evaluating the efficacy and safety of tacrolimus versus hydrocortisone as a topical treatment of atopic dermatitis in children
Background: Atopic dermatitis (AD) aetiology is not exactly identified, but it is characterized by pruritic skin reactions with elevation in the levels of inflammatory markers. Despite the fact that Corticosteroids are the mainstay therapy in the management of AD, they have many local and systemic a...
Main Authors: | Amal A. Mohamed, Radwa El Borolossy, Eman M. Salah, Maha S. Hussein, Nashwa M. Muharram, Naglaa Elsalawy, Mona G. Khalil, Maha O. Mahmoud, Reham Y. El-Amir, Heba M. A. Elsanhory, Nourelhuda Ahmed, Ahmed S. Adaroas, Mahmoud Montaser, Amal A. El Kholy |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1202325/full |
Similar Items
-
Commentary: A comparative randomized clinical trial evaluating the efficacy and safety of tacrolimus versus hydrocortisone as a topical treatment of atopic dermatitis in children
by: Jane Harvey, et al.
Published: (2024-02-01) -
Long-Term Efficacy and Safety of Dupilumab in Patients with Atopic Dermatitis: A Single-Centre Retrospective Study
by: Michela Ortoncelli, et al.
Published: (2023-11-01) -
Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023-07-01) -
Baricitinib provides rapid and sustained improvements in absolute EASI and SCORAD outcomes in adults with moderate-to-severe atopic dermatitis
by: Jacob P. Thyssen, et al.
Published: (2023-12-01) -
Tacrolimus Ointment for the Treatment of Atopic Dermatitis: Report of First Clinical Experience in Taiwan
by: Cheng-Che E. Lan, et al.
Published: (2003-06-01)